This section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Article content

TEL AVIV, Israel, Sept. 01, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva’s President and CEO, will present at three upcoming investor conferences in September as follows:

Sign In or Create an Account

or View more offersArticle content

  • Morgan Stanley 24th Annual Global Healthcare Conference
    Monday, September 14, 2026, at 8:30 A.M. Eastern Time (ET)
  • J.P. Morgan U.S. All Stars Conference 
    Tuesday, September 22, 2026, at 8:00 A.M. British Summer Time (3:00 A.M. ET)
  • BofA Global Healthcare Conference 2026  
    Wednesday, September 23, 2026, at 10:55 A.M. British Summer Time (5:55 A.M. ET)

Article contentWe apologize, but this video has failed to load.Try refreshing your browser, or
tap here to see other videos from our team.Article content

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

To access a live webcast of the presentation, visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations.

Article contentArticle content

An archived version of the webcast will be available within 24 hours after the end of the live discussion.

Article content

About Teva

Article content

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.

Article content

Cautionary Note Regarding Forward-Looking Statements

Article content

This Document and the presentation at the conferences may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as “should,” “expect,” “anticipate,” “estimate,” “target,” “may,” “project,” “guidance,” “intend,” “plan,” “believe” and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace, including our ability to successfully execute on our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and to profitably commercialize our innovative medicines and biosimilar portfolio, whether organically or through business development, to sustain and focus our portfolio of generic medicines, and to execute on our organizational transformation and to achieve expected cost savings; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in our Quarterly Report on Form 10-Q for the second quarter of 2026 and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the sections captioned “Risk Factors,” “Other Information” and “Forward Looking Statements.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

Article content

Teva Media Inquiries
[email protected]

Article content

Teva Investor Relations Inquiries
[email protected]

Article contentArticle content
Article contentArticle contentArticle contentArticle contentThis advertisement has not loaded yet.Trending


  1. Here’s how a growing pool of Canadians are paying off their mortgages

    Mortgages


  2. BYD asked about taking over Canadian Stellantis plant, mayor says

    Autos

  3. Story continues belowThis advertisement has not loaded yet, but your article continues below.

  4. It’s time for Canadian income tax rates to match those of the U.S.

    Personal Finance


  5. Posthaste: How Canada’s counter tariffs will pile more pain on the economy

    News


  6. Canadian refineries have never made so much off diesel as ‘Crackageddon’ mounts

    Energy